Psoriasis Risk Is Lower in Type 2 Diabetes Patients Using Dipeptidyl Peptidase-4 Inhibitors or Thiazolidinediones Compared to Sulfonylureas. - Chen WS; Lin TM; Chang YS; Shen YC; Hsu HC; Kuo TT; Chen SC; Chen JH; Chang CC (Clinical and translational science, 2025)